Asian equities have slipped on Friday morning after their counterparts on Wall Street gave up sessions gains to end little changed. Investors continue to weigh the signs of progress in the fight against Covid-19 and the resultant impact on economies.
Markets in Japan and South Korea are declining while those in Australia are fluctuating between gains and losses.
Futures on the S&P 500 are lower after the index gave up gains of as much as 1.6 % on Thursday to end little changed.
Gilead Sciences antiviral drug Remdesivir flopped in its first randomised clinical trial as per a Financial Times report that cited draft documents accidently published by the World Health Organisation.
Total job losses in the U.S. now stand at 26 million in the wake of the economic shutdown due to Covid-19.
🎯 News & Impact 🎯
🎯 Bharti Infratel Q4FY20 :
Revenue down 1.3 % to Rs 3,624.4 crore.
Net Profit down 18.7 % to Rs 649.5 crore.
Ebitda down 9.5 % at Rs 1,699 crore.
Ebitda Margins down to 46.9 % from 51.1 %
🎯 Ashok Leyland :
Increased its stake by 3.36 percent to 68.81 percent in its arm Hinduja Leyland Finance.
🎯 Hathway Cable & Datacom Q4FY20 :
Revenue up 19.6 % to Rs 455.7 crore.
Net profit up 7.3 times to Rs 48.8 crore.
Ebitda up 43.8 % to Rs 120.4 crore.
Ebitda Margins rise to 26.4 % from 22 %.
🎯 Alembic Pharma :
Company reported 81 percent rise in its consolidated net profit at Rs 224.93 crore for the fourth quarter ended March 31, 2020.
🎯 SBI Card :
Company reported outstanding borrowings worth Rs 17,362.86 crore at the end of March, 2020.
✒ ✒ ✒ ✒ ✒ ✒ ✒ ✒ ✒ ✒ ✒ ✒ ✒
Edited by Sharp.
No comments:
Post a Comment